Chronic Low Back Pain: TOTALSPINE - UO04
TOTALSPINE
Chronic Low Back Pain: Innovative E-healTh DiagnOstics and RehabiliTation Towards an IntegrAted and PersonaLized SPINE Care (TOTALSPINE) - UO04
2 other identifiers
interventional
86
1 country
2
Brief Summary
Background: Low back pain (LBP) is the primary factor contributing to years lived with disability. In view of the close correlation between the functions of the body, which cannot be examined piecemeal but as an integrated system, a holistic approach allows for a comprehensive assessment of the patient. The goal of our protocol is to identify all psychosocial risk factors that could worsen the patient's condition at the time of diagnosis by examining all possible related dimensions: cognitive function, anxiety and depression, pain perception, treatment adherence, the sexual sphere, family dynamics, social support, dysfunctional communication, quality of life while also considering attribution of causes. Methods: At least 86 patients will participate in the survey. At T0, they will undergo neuropsychological, psychological and associated clinical condition assessment through standardized tests and ad hoc questionnaires. After 1 month (T1), 2 months (T2) and 6 months (T3), the same tests will be repeated. Expected results: We expect this study to provide a comprehensive, in-depth, and integrated understanding of the patient, shedding light on the challenges they may face in managing chronic low back pain. Repeated administration of the questionnaires will allow us to monitor the patient over time, assess any changes in their health status, and structure an intervention tailored to their needs. Conclusions: By emphasizing these often neglected areas through a comprehensive, multi-step assessment, it will be possible to quantify and analyze how these risk factors can affect patients' well-being and hinder the treatment process and recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2024
CompletedFirst Submitted
Initial submission to the registry
February 27, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedMarch 28, 2025
August 1, 2024
1 year
February 27, 2025
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
psychosocial assessment through the use of tests to assess the extent of pain
The Pain Self-Efficacy Questionnaire (PSEQ), will be used to assess how patients maintain their autonomy despite perceived pain. This among the various measures that will be used is considered primary outcome
At the enrollment stage before the start of treatment
Study Arms (2)
Remote rehabilitation
EXPERIMENTALRemote therapy will be delivered for the experimental group to test the effectiveness of remote physiotherapy rehabilitation
Face-to-face rehabilitation
ACTIVE COMPARATORFor the control group, traditional face-to-face therapy will be delivered to test the difference with remote physiotherapy rehabilitation
Interventions
To develop and validate a quantitative assessment system based on wearable sensors
Compare the validity of face-to-face physiotherapy with remote physiotherapy
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years;
You may not qualify if:
- Past or present medical history of "red flags" (e.g., cancer, fractures, infections) or specific causes of non-discogenic LBP; 2) Having received physical therapy for LBP in the last 6 months;
- Previous spinal surgery;
- Severe or progressive neurological deficits;
- Any serious medical comorbidity that, in the opinion of the Principal Investigator (PI), would make participation unsafe or impossible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Irccs Centro Neurolesi Bonino Pulejo
Messina, Italy, 98124, Italy
Campus Biomedico Roma
Roma, IT, 00128, Italy
Related Publications (1)
Anselmo A, Pagano M, Corallo F, Cappadona I, Cardile D, Russo F, Laudisio A, Papalia GF, Quartarone A, Calabro RS. Psychosocial Assessment as a Key Component in an Integrated, Personalized Care Pathway: A Protocol for a Low Back Pain Randomized Controlled Trial. Pain Ther. 2025 Jun;14(3):1155-1168. doi: 10.1007/s40122-025-00741-7. Epub 2025 Apr 29.
PMID: 40299187DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Psychologist
Study Record Dates
First Submitted
February 27, 2025
First Posted
March 26, 2025
Study Start
August 31, 2024
Primary Completion
August 31, 2025
Study Completion (Estimated)
August 31, 2026
Last Updated
March 28, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
The personal data (IPD) that will be collected in this study are not available openly for sensitivity reasons and are available from the clinical trial protocol scientific officer upon reasonable request.